Tumor Suppressors Condition Differential Responses to the Selective CDK2 Inhibitor BLU-222. Dommer AP, Kumarasamy V, Wang J, O'Connor TN, et al. Cancer Res 2025;85:1310-1326.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Dommer AP, Kumarasamy V, Wang J, O'Connor TN, et al. Tumor Suppressors Condition Differential Responses to the Selective CDK2 Inhibitor BLU-222. Cancer Res 2025;85:1310-1326.
PMID: 39945638